NON SMALL CELL LUNG CANCER (STAGE III)
Clinical trials for NON SMALL CELL LUNG CANCER (STAGE III) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (STAGE III) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (STAGE III), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to keep early lung cancer at bay
Disease control OngoingThis study tests whether adding the drug durvalumab to precise radiation therapy (SBRT) can keep early-stage non-small cell lung cancer from coming back longer than radiation alone. It involves 13 adults with stage I to IIIA disease. The main goal is to see how long participants …
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
New pill may keep stage III lung cancer from returning
Disease control OngoingThis study tests whether taking osimertinib daily after standard chemoradiation can delay cancer growth in people with stage III EGFR-mutated non-small cell lung cancer that hasn't spread. About 216 participants worldwide will receive either osimertinib or a placebo. The goal is …
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Gut bacteria may hold key to lung cancer treatment success
Knowledge-focused OngoingThis study looks at whether bacteria from throat swabs, stool, and lung samples can help predict which patients with stage III lung cancer will have their cancer return during immunotherapy (durvalumab) after chemoradiation. Researchers will also check how antibiotics affect trea…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Leiden University Medical Center • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Blood test may predict lung cancer outcomes before surgery
Knowledge-focused OngoingThis study tracks 100 people with stage IIIA lung cancer who receive treatment before surgery. Researchers check for tumor DNA in the blood after treatment and before surgery to see if its disappearance is linked to longer survival. The goal is to learn if this blood test can hel…
Matched conditions: NON SMALL CELL LUNG CANCER (STAGE III)
Sponsor: Fundación GECP • Aim: Knowledge-focused
Last updated May 14, 2026 12:03 UTC